Pathophysiology of hepatic encephalopathy: The concept of synergism

Hepatology Research

Volumn 38, Issue SUPPL. 1, 2008, Pages

  Butterworth, Roger F ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Ammonia; Astrocyte; Cytokines; Hepatic encephalopathy; Manganese; Synergism

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; AMMONIA; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; BENZODIAZEPINE RECEPTOR; BENZOIC ACID; CYTOKINE; CYTOKINE ANTIBODY; GLUTAMATE RECEPTOR; GLUTAMIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTULOSE; MANGANESE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROSTEROID; OCTANOIC ACID; ORNITHINE ASPARTATE; SARMAZENIL; THIOL DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; AMMONIA FORMATION; ASTROCYTOSIS; BRAIN EDEMA; CONFERENCE PAPER; DEATH; HEPATIC COMA; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER FAILURE; LIVER NECROSIS; LIVER TRANSPLANTATION; NEUROMODULATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 58049083992     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00436.x     Document Type: Conference Paper

References (32)

1. Ferenci P, Lockwood A, Mullen K etal. Hepatic encephalopathy -definition, nomenclature, diagnosis and quantification: Final report of the working party at the 11th World Congress of Gastroenterology, Vienna 1998. Hepatology 2002; 35: 716-21.
2. Bélanger M, Desjardins P, Chatauret N, Butterworth RF. Loss of expression of glial fibrillary acidic protein in acute hyperammonemia. Neurochem Int 2002; 41: 155-60.
3. Bélanger M, Desjardins P, Chatauret N, Butterworth RF. Selectively increased expression of the astrocytic/endothelial glucose transporter protein GLUT1 in acute liver failure (p NA). Glia 2006; 53: 557-62.
4. Butterworth RF. Neuronal cell death in hepatic encephalopathy. Metab Brain Dis 2007; 22: 309-20.
5. Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with ALF is correlated with arterial ammonia concentration. Hepatology 1999; 29: 648-53.
6. Lockwood AH, Lockwood AH, Yap EWH, Wong W-H. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cerebral Blood Flow and Metab 1991; 11: 337-41.
7. Pomier-Layrargues G, Spahr L, Butterworth RF. Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 1995; 354: 735.
8. Mousseau DD, Perney P, Pomier Layrargues G, Butterworth RF. Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy. Neurosci Lett 1993; 162: 192-6.
9. Kato A, Watanabe Y, Sawara K etal. Regional cerebral dopamine receptor binding activities in patients with liver cirrhosis: Results on positron emission tomography using [11C]-methylspiperone. Hepatology 2006; 44: Suppl 1): A441.
10. Jalan R, Olde Damink SW, Deutz NE et al. Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation 2003; 75: 2034-9.
11. Jiang W, Desjardins P, Ahboucha S, Qu H, Butterworth RF. Selective increases in expression of proinflammatory cytokines in brains of rats with experimental ischemic liver failure. Neurochem Int 2008 (in press).
12. Zieve L, Doizaki WM, Zieve J. Synergism between mercaptans and ammonia or fatty acids in the production of coma: A possible role for mercaptans in the pathogenesis of hepatic coma. J Lab Clin Med 1974; 83: 16-28.
13. Blei AT. Infection, inflammation and hepatic encephalopathy, synergism redefined. J Hepatol 2004; 40: 327-30.
14. Lavoie J, Pomier Layrargues G, Butterworth RF. Increased densities of "peripheral-type" benzodiazepine receptors in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Hepatology 1990; 11: 874-8.
15. Desjardins P, Bandeira P, Raghavendra Rao VL, Ledoux S, Butterworth RF. Increased expression of the peripheral-type benzodiazepine receptor-isoquinoline carboxamide binding protein in mRNA brain following portacaval anastomosis. Brain Res 1997; 758: 255-8.
16. Bélanger M, Desjardins P, Chatauret N, Rose C, Butterworth RF. Mild hypothermia prevents brain edema and attenuates up-regulation of the astrocytic benzodiazepine receptor in experimental acute liver failure. J Hepatol 2005; 42: 694-9.
17. Cagnin A, Taylor-Robinson SD, Forton DM, Banati RB. In vivo quantification of cerebral "peripheral benzodiazepine binding site" in minimal Hepatic Encephalopathy: A [11 C]R-PK11195 Positron Emission Tomography study. J Hepatol 2001; 34: 58.
18. Desjardins P, Butterworth RF. The "peripheral-type" benzodiazepine (omega 3) receptor in hyperammonemic disorders. Neurochem Int 2002; 41: 109-14.
19. Ahboucha S, Pomier-Layrargues G, Mamer O, Butterworth RF. Increased brain concentrations of a neuroinhibitory steroid in human hepatic encephalopathy. Ann Neurol 2005; 58: 169-70.
20. Ahboucha S, Butterworth RF. The neurosteroid system: An emerging therapeutic target for hepatic encephalopathy. Metab Brain Dis 2007; 22: 291-308.
21. Norenberg MD. Astroglial dysfunction in hepatic encephalopathy. Metab Brain Dis 1998; 13: 319-35.
22. Hazell AS, Desjardins P, Butterworth RF. Chronic exposure of rat primary astrocyte cultures to manganese results in increased binding sites for the "peripheral-type" benzodiazepine receptor ligand 3H-PK 11195. Neurosci Lett 1999; 271: 5-8.
23. Knecht K, Michalak A, Rose C, Rothstein JD, Butterworth RF. Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with acute liver failure. Neurosci Lett 1997; 229: 201-3.
24. Suarez I, Bodega G, Fernandez B. Modulation of glutamate transporters (GLAST, GLT-1, EAAC1) in the rat cerebellum following portacaval anastomosis. Brain Res 2000; 859: 293-302.
25. Chan H, Butterworth RF. Glutamatergic synaptic regulation deficit in liver failure: A review of molecular mechanisms. In: Haüssinger D, Kircheis G, Schliess F, eds. Hepatic Encephalopathy And Nitrogen Metabolism. Dordrecht. The Netherlands: Springer, 2006; 160-70.
26. Hu S, Sheng WS, Ehrlich LC, Peterson PK, Chao CC. Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 2000; 7: 153-9.
27. Danbolt NC. Glutamate uptake. Prog Neurobiol 2001; 65: 1-105.
28. Rose C, Butterworth RF, Zayed J et al. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 1999; 117: 640-4.
29. Felipo V, Butterworth RF. Neurobiology of ammonia. Prog Neurobiol 2002; 67: 259-79.
30. Schliess F, Görg B, Fischer R etal. Ammonia induces MK-801 sensitive nitration and phosphorylation of protein tyrosine residues in rat astrocytes. FASEB J 2002; 16: 739-41.
31. Meyer HP, Legemate DA, van den Brom W, Rothuizen J. Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil. Metab Brain Dis 1998; 13: 241-51.
32. Vogels BA, Maas MA, Daalhuisen J, Quack G, Chamuleau RA. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats. Hepatology 1997; 25: 820-7.